超声引导高强度聚焦超声消融治疗黑人女性症状性子宫肌瘤的疗效与安全性:初步研究
本研究为可行性研究,纳入26例黑人绝经前女性共53个子宫肌瘤,接受超声引导高强度聚焦超声治疗。中位肌瘤体积52.7 cm³,平均消融率80.6±9.7%,术中常见下腹痛(69.2%)等,未观察到严重并发症,作者认为该治疗可行且安全。
要点
- 26例黑人绝经前女性53个子宫肌瘤接受USgHIFU治疗。
- 平均消融率80.6±9.7%,中位肌瘤体积52.7 cm³。
- 术中69.2%患者报告下腹痛,未观察到严重并发症。
核心结论
- 作者认为USgHIFU用于治疗黑人女性症状性子宫肌瘤是可行且安全的。
研究设计与样本
- 可行性研究,纳入26例黑人绝经前女性共53个子宫肌瘤,接受USgHIFU治疗。
- 研究地点为南非一家教学医院的妇科。
主要发现
- 中位肌瘤体积为52.7 cm³(四分位距18.6-177.4 cm³)。
- 治疗总能量298.6±169.3 kJ(范围76.0-889.2 kJ),治疗时间90.3±43.3分钟(范围14.0-208.0分钟),其中声照时间774.0±432.9秒(范围190.0-2224.0秒)。
- 平均消融率为80.6±9.7%(范围46.5-94.5%)。
- 术中69.2%患者报告下腹痛,57.7%报告坐骨神经/臀部疼痛,38.5%报告皮肤灼烧感,34.6%报告短暂腿痛。
- 未观察到严重并发症。
关键数值与推荐
- 原文未报告指南或共识推荐条款。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the therapeutic effect and safety of ultrasound-guided high-intensity focused ultrasound (USgHIFU) treatment on symptomatic uterine fibroids in Black women. DESIGN: A feasibility study. SETTING: Gynaecological department in a teaching hospital in South Africa. POPULATION: Premenopausal women with uterus fibroids. METHODS: Twenty-six patients with 53 fibroids who underwent USgHIFU treatment were enrolled. The USgHIFU treatment information was recorded, including treatment time, sonication time and total energy. Adverse events were also observed and recorded during and after treatment. MAIN OUTCOME MEASURES: Safety and efficacy of USgHIFU for the treatment of uterine fibroids in Black women. RESULTS: The median volume of fibroids was 52.7 (interquartile range, 18.6-177.4) cm3 . According to USgHIFU treatment plan, total energy of 298.6 ± 169.3 kJ (range, 76.0-889.2) within treatment time of 90.3 ± 43.3 minutes (range, 14.0-208.0), in which sonication time of 774.0 ± 432.9 seconds (range, 190.0-2224.0) was used to ablate fibroids. The average ablation rate was 80.6 ± 9.7% (range, 46.5-94.5%). During the procedure, 69.2% of the patients reported lower abdominal pain, 57.7% sciatic/buttock pain, 38.5% burning skin, and 34.6% transient leg pain. No severe complications were observed. CONCLUSIONS: USgHIFU is feasible and safe to use to treat symptomatic uterine fibroids in Black women. TWEETABLE ABSTRACT: Multiple uterine fibroids are more frequently detected in Black women. USgHIFU is feasible and safe for the treatment of uterine fibroids in Black women.
引用
- Zhang C, Jacobson H, Ngobese ZE, et al. Efficacy and safety of ultrasound-guided high intensity focused ultrasound ablation of symptomatic uterine fibroids in Black women: a preliminary study. BJOG. 2017. PMID: 28856855. doi:10.1111/1471-0528.14738
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。